ArticleCellular oncology (Dordrecht, Netherlands)2025

Pyrotinib inhibits the tumorigenicity of HER2-positive non-small cell lung cancer by inducing ARIH1/ubiquitin/lysosome-dependent degradation of HER2.

Xiyue Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.